You are here: Industry Insights > aurobindo pharma

News List

Pricing problems: Aurobindo Pharma, Sun Pharma, Lupin named in lawsuit in US expresspharma
June 16, 2020
Attorney General Brian E Frosh in a statement issued on Wednesday said the new complaint, filed in the U.S. District Court for the District of Connecticut, focuses on 80 topical generic drugs ...
Teva moves US court against Aurobindo Pharma on cancer drug Bendeka expresspharma
May 15, 2020
A probable patent infringement petition against Aurobindo in the US district court for the District of Delaware on 28 counts.
Aurobindo Pharma receives USFDA approval for Flucytosine Capsules expresspharma
May 04, 2020
Flucytosine Capsules are indicated for the treatment of serious infections caused by susceptible strains of Candida and/or Cryptococcus.
Technology has driven success in pharma industry in many perceptible ways expresspharma
April 30, 2020
Gyan Pandey, Global and Group CIO, Aurobindo Pharma, explains that digitalisation is not a one-time process, but an evolving journey.
PharmaStory Aurobindo Pharma gets VAI classification from US regulator for Hyderabad unit expresspharma
April 22, 2020
The inspection of Unit IV at Hyderabad, an injectable manufacturing formulation facility of the company, was conducted between November 4-13, 2019 by the US FDA.
Aurobindo Pharma gets US FDA nod for generic antidepressant tablets expresspharma
April 13, 2020
Drug firm Aurobindo Pharma said that it has received the final nod from the US health regulator for its generic anti-depressant Fluoxetine tablets.
Aurobindo, Sandoz call off $900 million deal expresspharma
April 03, 2020
In September 2018, Aurobindo Pharma had said its US subsidiary has entered into a pact to acquire commercial operations and three manufacturing facilities in America from Sandoz Inc.
Aurobindo Pharma net surges 39.5 per cent to Rs 636 crore expresspharma
August 09, 2019
Revenues stood at Rs 5,444.6 crore against Rs 4,250.3 crore and witnessed a strong growth of 28.1 per cent
Aurobindo Pharma gets 10 observations from USFDA for its Unit 3 at Hyderabad expressbpd
June 06, 2019
Aurobindo Pharma gets 10 observations from USFDA for its Unit 3 at Hyderabad - BPD
Aurobindo Pharma Adds to Nationwide Valsartan Blood Pressure Medication Recall americanpharmaceuticalreview
January 14, 2019
Aurobindo Pharma is conducting a voluntary recall of 80 lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets USP and Valsartan Tablets USP to the consumer level due to the detection of trace amounts of .....

Previous page 1 2 3 Next page